Pharmacological Activities of Safflower Yellow and Its Clinical Applications

被引:24
作者
Chen, Yan [1 ,2 ,3 ]
Li, Meifeng [1 ]
Wen, Jiayu [2 ]
Pan, Xiaoqi [2 ]
Deng, Zixin [2 ]
Chen, Junren [1 ,3 ]
Chen, Guanru [1 ,3 ]
Yu, Lei [1 ,3 ]
Tang, Yunli [1 ,2 ,4 ]
Li, Gangmin [1 ,3 ]
Xie, Xiaofang [1 ,3 ]
Peng, Cheng [1 ,3 ]
机构
[1] State Key Lab Southwestern Chinese Med Resources, Chengdu 611137, Peoples R China
[2] Chengdu Univ Tradit Chinese Med, Sch Publ Hlth, Chengdu 611137, Peoples R China
[3] Chengdu Univ Tradit Chinese Med, Coll Pharm, Chengdu 611137, Peoples R China
[4] Guangxi Univ Tradit Chinese Med, Natl Engn Res Ctr Mfg Technol Solid Preparat Tradi, South China Branch, Nanning 530200, Guangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
HYDROXYSAFFLOR YELLOW; CARTHAMUS-TINCTORIUS; ANGINA-PECTORIS; BREAST-CANCER; IN-VIVO; INJURY; METASTASIS; INJECTION; APOPTOSIS; CELLS;
D O I
10.1155/2022/2108557
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background. Safflower is an annual herb used in traditional Chinese herbal medicine. It consists of the dried flowers of the Compositae plant safflower. It is found in the central inland areas of Asia and is widely cultivated throughout the country. Its resistance to cold weather and droughts and its tolerance and adaptability to salts and alkalis are strong. Safflower has the effect of activating blood circulation, dispersing blood stasis, and relieving pain. A natural pigment named safflower yellow (SY) can be extracted from safflower petals. Chemically, SY is a water-soluble flavonoid and the main active ingredient of safflower. The main chemical constituents, pharmacological properties, and clinical applications of SY are reviewed in this paper, thereby providing a reference for the use of safflower in preventing and treating human diseases. Methods. The literature published in recent years was reviewed, and the main chemical components of SY were identified based on chemical formula and structure. The pharmacological properties of hydroxysafflor yellow A (HSYA), SYA, SYB, and anhydrosafflor yellow B (AHSYB) were reviewed. Results. The main chemical constituents of SY included HSYA, SYA, SYB, and AHSYB. These ingredients have a wide range of pharmacological activities. SY has protective effects on the heart, kidneys, liver, nerves, lungs, and brain. Moreover, its effects include, but are not limited to, improving cardiovascular and cerebrovascular diseases, abirritation, regulating lipids, and treating cancer and diabetic complications. HSYA is widely recognised as an effective ingredient to treat cardiovascular and cerebrovascular diseases. Conclusion. SY has a wide range of pharmacological activities, among which improving cardiovascular and cerebrovascular diseases are the most significant.
引用
收藏
页数:24
相关论文
共 145 条
  • [1] Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum
    Ali, Ahmed Y.
    Farrand, Lee
    Kim, Ji Young
    Byun, Sanguine
    Suh, Jeong-Yong
    Lee, Hyong Joo
    Tsang, Benjamin K.
    [J]. NUTRITION AND PHYSICAL ACTIVITY IN AGING, OBESITY, AND CANCER, 2012, 1271 : 58 - 67
  • [2] Hydroxysafflor Yellow A: A Promising Therapeutic Agent for a Broad Spectrum of Diseases
    Ao, Hui
    Feng, Wuwen
    Peng, Cheng
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018
  • [3] Therapeutic Potential of Hydroxysafflor Yellow A on Cardio-Cerebrovascular Diseases
    Bai, Xue
    Wang, Wen-Xiao
    Fu, Rui-Jia
    Yue, Shi-Jun
    Gao, Huan
    Chen, Yan-Yan
    Tang, Yu-Ping
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [4] Bao Q.L, 2018, CHINESE J GASTROENTE, V38, P5386
  • [5] Bharat B., 2019, HEPATOLOGY, V70
  • [6] Bumandorj B, 2015, J INNER MONGOLIA U, V46, P301
  • [7] Cytoprotective Effect of Antioxidant Pentapeptides from the Protein Hydrolysate of Swim Bladders of Miiuy Croaker (Miichthys miiuy) against H2O2-Mediated Human Umbilical Vein Endothelial Cell (HUVEC) Injury
    Cai, Shi-Ying
    Wang, Yu-Mei
    Zhao, Yu-Qin
    Chi, Chang-Feng
    Wang, Bin
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (21)
  • [8] The selective effect of glycyrrhizin and glycyrrhetinic acid on topoisomerase IIα and apoptosis in combination with etoposide on triple negative breast cancer MDA-MB-231 cells
    Cai, Yun
    Zhao, Boxin
    Liang, Qianying
    Zhang, Yunqi
    Cai, Jieying
    Li, Guofeng
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 809 : 87 - 97
  • [9] Astragaloside and/or Hydroxysafflor Yellow A Attenuates Oxygen-Glucose Deprivation-Induced Cultured Brain Microvessel Endothelial Cell Death through Downregulation of PHLPP-1
    Cao, Jinyi
    Wang, Kai
    Lei, Lu
    Bai, Lu
    Liang, Ruimin
    Qiao, Yi
    Duan, Jialin
    Gao, Kai
    Cao, Shanshan
    Zhao, Chao
    Yang, Zhifu
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [10] Chen C, 2011, CHIN INS PHARM BIOL